LSV Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Buy |
95,200
+13,100
| +16% | +$313K | 0.01% | 539 |
|
|
2025
Q1 | $2.04M | Buy |
82,100
+64,800
| +375% | +$1.61M | ﹤0.01% | 562 |
|
|
2024
Q4 | $326K | Sell |
17,300
-12,600
| -42% | -$237K | ﹤0.01% | 717 |
|
|
2024
Q3 | $450K | Buy |
29,900
+13,767
| +85% | +$207K | ﹤0.01% | 712 |
|
|
2024
Q2 | $462K | Buy |
+16,133
| New | +$462K | ﹤0.01% | 735 |
|